At ViVE 2026, we kept the AI conversation grounded

Most panels go big and abstract. At ViVE 2026 in Los Angeles, Transcend's CIO & CISO in Residence, Aimee Cardwell and Morgan Sullivan, Senior Marketing Manager, went the other direction, anchoring the entire session around one use case: the GLP-1 patient journey.

It’s a timely example. GLP-1 treatments are driving unprecedented growth and, with it, a shift in how organizations engage with patients. Pharmaceutical companies are building direct, opt-in relationships from a relatively clean slate. Healthcare providers, by contrast, are working across years of fragmented systems, acquisitions, and siloed data.

That difference shows up quickly in practice. Every patient interaction (a reminder, a coupon, a follow-up) creates a consent event. Capturing that “yes” is straightforward. Making it usable across dozens of systems is not.

Instead of trying to centralize and clean everything, the conversation focused on a more practical path. A consent layer can sit on top of existing systems, making those signals usable in real time without requiring a full rebuild of the underlying data.

As Cardwell put it: “Put a consent layer on top of it, and then find a use case that you know is going to be beneficial both to the user and to the business. Try it out once. Adapt it until it works.”

Watch the full session below.